Vault-13

Ponoi II Management, LLC

San Francisco, CA · CIK 1746488 · 13F filing filed 2021-08-16

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$123.4m reported value -5.5% vs Q1 2021
5positions
100.0%in top 10
0 new 0 added 0 reduced 0 sold out vs Q1 2021

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CONSTELLATION PHARMCETICLS I COM CNST CNST 1,574,229 $53.2m43.12% 43.12% UnchangedShares held: Q3 2020 0, Q4 2020 1.6m, Q1 2021 1.6m, Q2 2021 1.6m
2 NGM BIOPHARMACEUTICALS INC COM NGM NGM 1,298,908 $25.6m20.76% 20.76% UnchangedShares held: Q3 2020 0, Q4 2020 1.3m, Q1 2021 1.3m, Q2 2021 1.3m
3 REVOLUTION MEDICINES INC COM RVMD RVMD 685,011 $21.7m17.62% 17.62% UnchangedShares held: Q3 2020 0, Q4 2020 685.0k, Q1 2021 685.0k, Q2 2021 685.0k
4 NURIX THERAPEUTICS INC COM NRIX NRIX 686,274 $18.2m14.76% 14.76% UnchangedShares held: Q3 2020 0, Q4 2020 686.3k, Q1 2021 686.3k, Q2 2021 686.3k
5 RAPT THERAPEUTICS INC COM COM 145,401 $4.6m3.75% 3.75% UnchangedShares held: Q3 2020 0, Q4 2020 145.4k, Q1 2021 145.4k, Q2 2021 145.4k